SNCA and Parkinson disease: Simultaneous mutations in both GBA and SNCA gene has been shown to aggravate the PD phenotype in a transgenic mice that harbors the GBA mutation (p.L444P) that leads to 40% reduction in GCases enzyme activity when co-expressed with the SNCA A53T mutation.